Hemab Therapeutics (COAG)
Develops preventive therapies for rare bleeding and coagulation disorders.
$44.11
Pre-market−0.54 (−1.21%)
At close$44.65(+1.43%)
Something off on this page? Send us feedback.
EPSReportedEstimate
——————May '26Aug '26
Reported——————−$23.98−$0.80
Estimate——————−$23.25−$0.73
Surprise——————−3.2%−9.2%
RevenueReportedEstimate
——————May '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.73 | −$0.80 | −9.2% |
| May 2026 | −$23.25 | −$23.98 | −3.2% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | −$0.73 | −$0.80 | −9.2% | — | — | — | +3.8% |
| May 21, 2026 | −$23.25 | −$23.98 | −3.2% | — | — | — | −1.6% |